-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on I-Mab (IMAB)
-
-
-
-
-
-
-
I-Mab Announces Leadership Transitions
-
-
-
-
-
-
-
AbbVie to Showcase Oncology Portfolio and Pipeline During the 2022 ASCO and EHA Annual Congresses
-
-
-
-
-
-
-
AbbVie Reports Full-Year and Fourth-Quarter 2021 Financial Results
-
-
-
-
-
-
-
AbbVie to Highlight New Advances in Blood Cancer Research and Expanding Oncology Pipeline at 63rd ASH Annual Meeting
-
-
-
-
-
-
-
AbbVie Reports Full-Year and Fourth-Quarter 2020 Financial Results
-
-
-
-
-
-
-
AbbVie and I-Mab Enter into Global Strategic Partnership for Differentiated Immuno-oncology Therapy
-
1,155,194 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

